DUSP4
Basic information
Region (hg38): 8:29333064-29350684
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DUSP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 18 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 3 | 0 |
Variants in DUSP4
This is a list of pathogenic ClinVar variants found in the DUSP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-29337037-G-C | not specified | Uncertain significance (Jul 12, 2022) | ||
8-29337061-G-C | not specified | Uncertain significance (Jun 05, 2023) | ||
8-29337091-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
8-29337097-C-T | not specified | Uncertain significance (May 13, 2024) | ||
8-29337118-C-T | not specified | Uncertain significance (May 01, 2024) | ||
8-29337139-C-G | not specified | Likely benign (Dec 20, 2023) | ||
8-29337189-G-A | not specified | Likely benign (Sep 09, 2024) | ||
8-29337190-C-A | not specified | Uncertain significance (Oct 10, 2023) | ||
8-29337273-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
8-29337283-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
8-29337365-C-T | Likely benign (Mar 01, 2023) | |||
8-29337391-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
8-29338344-G-C | not specified | Uncertain significance (Jan 19, 2024) | ||
8-29338413-G-T | not specified | Uncertain significance (Mar 20, 2024) | ||
8-29338443-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
8-29338444-G-A | not specified | Uncertain significance (Sep 06, 2022) | ||
8-29338484-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
8-29338487-C-A | not specified | Uncertain significance (Mar 16, 2022) | ||
8-29340104-G-A | Likely benign (Nov 01, 2022) | |||
8-29340112-G-C | not specified | Uncertain significance (Aug 12, 2024) | ||
8-29340139-C-A | not specified | Uncertain significance (Nov 10, 2022) | ||
8-29340145-G-C | not specified | Uncertain significance (Sep 21, 2023) | ||
8-29340168-G-A | not specified | Uncertain significance (May 25, 2022) | ||
8-29340169-G-A | not specified | Uncertain significance (May 15, 2024) | ||
8-29340181-C-T | not specified | Uncertain significance (May 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DUSP4 | protein_coding | protein_coding | ENST00000240100 | 4 | 17605 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.882 | 0.118 | 125522 | 0 | 5 | 125527 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.49 | 179 | 245 | 0.732 | 0.0000142 | 2519 |
Missense in Polyphen | 49 | 92.634 | 0.52896 | 923 | ||
Synonymous | 0.615 | 104 | 112 | 0.926 | 0.00000714 | 836 |
Loss of Function | 2.84 | 1 | 11.3 | 0.0882 | 4.82e-7 | 141 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000493 | 0.0000441 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates mitogenic signal transduction by dephosphorylating both Thr and Tyr residues on MAP kinases ERK1 and ERK2. {ECO:0000269|PubMed:7535768}.;
- Pathway
- MAPK signaling pathway - Homo sapiens (human);EGF-Ncore;Endoderm Differentiation;MAPK Signaling Pathway;Toll Like Receptor 7/8 (TLR7/8) Cascade;Interleukin-17 signaling;Signal Transduction;Signaling by Interleukins;regulation of map kinase pathways through dual specificity phosphatases;Cytokine Signaling in Immune system;Toll Like Receptor 9 (TLR9) Cascade;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll-Like Receptors Cascades;Innate Immune System;Immune System;Nuclear Events (kinase and transcription factor activation);RAF-independent MAPK1/3 activation;ERKs are inactivated;Signaling by NTRK1 (TRKA);Signaling by NTRKs;ERK/MAPK targets;MAPK targets/ Nuclear events mediated by MAP kinases;MAP kinase activation;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;Negative regulation of MAPK pathway;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88-independent TLR4 cascade ;Toll Like Receptor 4 (TLR4) Cascade;Signaling by Receptor Tyrosine Kinases;MyD88:Mal cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll Like Receptor 2 (TLR2) Cascade
(Consensus)
Recessive Scores
- pRec
- 0.312
Intolerance Scores
- loftool
- 0.375
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24.19
Haploinsufficiency Scores
- pHI
- 0.211
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.980
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dusp4
- Phenotype
- hematopoietic system phenotype; limbs/digits/tail phenotype; immune system phenotype; skeleton phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- dusp4
- Affected structure
- endodermal cell
- Phenotype tag
- abnormal
- Phenotype quality
- increased amount
Gene ontology
- Biological process
- inactivation of MAPK activity;dephosphorylation;peptidyl-tyrosine dephosphorylation;peptidyl-threonine dephosphorylation;negative regulation of ERK1 and ERK2 cascade
- Cellular component
- nucleus;nucleoplasm;cytoplasm
- Molecular function
- protein tyrosine phosphatase activity;protein binding;protein tyrosine/serine/threonine phosphatase activity;protein tyrosine/threonine phosphatase activity;phosphatase activity;MAP kinase tyrosine/serine/threonine phosphatase activity;MAP kinase serine/threonine phosphatase activity